Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Purple Biotech (PPBT) Return on Equity (2016 - 2025)

Purple Biotech has reported Return on Equity over the past 5 years, most recently at 0.0% for Q4 2022.

  • Quarterly Return on Equity changed 0.0% to 0.0% in Q4 2022 from the year-ago period, while the trailing twelve-month figure was 0.0% through Dec 2022, changed 0.0% year-over-year, with the annual reading at 0.0% for FY2022, 0.0% changed from the prior year.
  • Return on Equity was 0.0% for Q4 2022 at Purple Biotech, down from 0.0% in the prior quarter.
  • Over five years, Return on Equity peaked at 0.01% in Q4 2018 and troughed at 0.0% in Q2 2021.
  • The 5-year median for Return on Equity is 0.0% (2022), against an average of 0.0%.
  • Year-over-year, Return on Equity changed 0bps in 2019 and then decreased -1bps in 2020.
  • A 5-year view of Return on Equity shows it stood at 0.01% in 2018, then dropped by -28bps to 0.01% in 2019, then plummeted by -91bps to 0.0% in 2020, then plummeted by -81bps to 0.0% in 2021, then skyrocketed by 1472bps to 0.0% in 2022.
  • Per Business Quant, the three most recent readings for PPBT's Return on Equity are 0.0% (Q4 2022), 0.0% (Q3 2022), and 0.0% (Q2 2022).